Immunome (IMNM) Other financing activities (2020 - 2026)
Immunome (IMNM) posted Other financing activities of $229000.0 for Q1 2026, up 207.51% on a QoQ basis from -$213000.0 in Q2 2025, and up 7.51% year-over-year from $213000.0 in Q1 2025.
Immunome (IMNM) Other financing activities (2020 - 2026) Analysis & Trends
Immunome's Other financing activities history runs 7 years deep, the most recent figure standing at $229000.0 for Q1 2026.
- Quarterly Other financing activities rose 7.51% year-over-year to $229000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16000.0 (up 101.34% YoY) and the FY2024 annual result came in at $2.0 million, down 98.38% from the prior year.
- Other financing activities was $229000.0 for Q1 2026 at Immunome, up from -$213000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $64.0 million in Q4 2023 and bottomed at -$1.7 million in Q4 2024.
- A 5-year average of $8.3 million and a median of $221000.0 in 2025 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2022 — Other financing activities soared 433.33% — and 2025, when it slumped 171.0%.
- Immunome's Other financing activities stood at $32000.0 in 2022, then soared by 199900.0% to $64.0 million in 2023, then sank by 102.67% to -$1.7 million in 2024, then jumped by 87.52% to -$213000.0 in 2025, then surged by 207.51% to $229000.0 in 2026.
- Business Quant data shows IMNM's Other financing activities at $229000.0 in Q1 2026, -$213000.0 in Q2 2025, and $213000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immunome | 2.49 Bn | 1.91 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 229,000.00 |
| Mar 31, 2026 | 229,000.00 |
| Jun 30, 2025 | -213,000.00 |
| Jun 30, 2025 | -213,000.00 |
| Mar 31, 2025 | 213,000.00 |
| Mar 31, 2025 | 213,000.00 |
| Dec 31, 2024 | -1.71 Mn |
| Dec 31, 2024 | -1.71 Mn |
| Jun 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 3.43 Mn |
| Mar 31, 2024 | 3.43 Mn |
| Dec 31, 2023 | 64.00 Mn |
| Dec 31, 2023 | 64.00 Mn |
| Mar 31, 2022 | 32,000.00 |
| Mar 31, 2022 | 32,000.00 |
| Dec 31, 2021 | 25,000.00 |
| Dec 31, 2021 | 25,000.00 |
| Sep 30, 2021 | 47,000.00 |
| Sep 30, 2021 | 47,000.00 |